Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy

BACKGROUND: Professional society practice guidelines conflict regarding their recommendations of dofetilide (DOF) and sotalol (STL) for treatment of arrhythmias in hypertrophic cardiomyopathy (HCM), and supporting data is sparse. We aim to assess safety and efficacy of DOF and STL on arrhythmias in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chris, Lal, Mallika, Burton, Yunwoo, Chen, Hongya, Stecker, Eric, Masri, Ahmad, Nazer, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356938/
https://www.ncbi.nlm.nih.gov/pubmed/37468544
http://dx.doi.org/10.1038/s43856-023-00315-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356938/
https://www.ncbi.nlm.nih.gov/pubmed/37468544
http://dx.doi.org/10.1038/s43856-023-00315-8

Ejemplares similares